Stealth BioTherapeutics
James D. Wakefield is a seasoned professional in clinical pharmacology and drug metabolism and pharmacokinetics (DMPK), currently serving as Senior Director at Stealth BioTherapeutics since April 2022. Previously, James held leadership roles at Acceleron Pharma, where as Director of Clinical Pharmacology, strategic clinical pharmacology initiatives were developed for drug programs. Prior experiences at Cyclerion and Ironwood Pharmaceuticals involved directing clinical pharmacology efforts and managing DMPK functions, respectively, contributing significantly to both preclinical and clinical development. James's career began at Praecis Pharmaceuticals, where contributions spanned analytical chemistry and the establishment of pharmacology capabilities. James holds a Master of Science in Biotechnology from Northwestern University and a Bachelor of Science in Biochemistry from Texas A&M University.
This person is not in any teams
This person is not in any offices
Stealth BioTherapeutics
1 followers
Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging.